Dysregulated proline metabolism contributes to retinal fibrosis in neovascular AMD: Therapeutic potential of prolyl-4-hydroxylase inhibition
Molecular Therapy
· Elsevier
Abstract
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Yue Zeng, Ting Zhang, Elisa Cornish, So-Ra Lee, Michelle Yam, Mark Eminhizer, Jingwen Zeng, Jialing Zhang, Shaoxue Zeng, Azhar Dzulhadj B. Arafah, Xian Wei, Jinliang Yang, Meidong Zhu, Andrew Chang, Meixia Zhang, Jianhai Du, Ling Zhu, Mark C. Gillies
Read at publisher →
Cite
Get new articles on “Drug Discovery”
Subscriptions, keyword tracking and favourites — in the Articlium Telegram bot.
Open in Telegram
Citation
✕
ГОСТ
APA
MLA
BibTeX
Dysregulated proline metabolism contributes to retinal fibrosis in neovascular AMD: Therapeutic potential of prolyl-4-hydroxylase inhibition. // Molecular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S1525001626006659?dgcid=rss_sd_all
Dysregulated proline metabolism contributes to retinal fibrosis in neovascular AMD: Therapeutic potential of prolyl-4-hydroxylase inhibition. Molecular Therapy. https://www.sciencedirect.com/science/article/pii/S1525001626006659?dgcid=rss_sd_all
“Dysregulated proline metabolism contributes to retinal fibrosis in neovascular AMD: Therapeutic potential of prolyl-4-hydroxylase inhibition.” Molecular Therapy.
@article{article117396,
title = {Dysregulated proline metabolism contributes to retinal fibrosis in neovascular AMD: Therapeutic potential of prolyl-4-hydroxylase inhibition},
journal = {Molecular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S1525001626006659?dgcid=rss_sd_all}
}